Dr. Vamsidhar Velcheti with the Cleveland Clinic joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses MET as a target in advanced non-small cell lung cancer.
Dr. Alice Shaw joined GRACE to discuss the changing landscape of first-line treatment of ALK-positive advanced non-small cell lung cancer.
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for first-line treatment.
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy combined.
Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy with chemotherapy.
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now for this paid opportunity to tell...
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now for this paid opportunity to tell...
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now for this paid opportunity to tell...
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now for this paid opportunity to tell...
I’m a 33, turning 34 next month healthy female- In the past 4 months my dr has been watching my bloodwork for a slightly elevated d dimer .55 and ha...
I’m a 33, turning 34 next month healthy female- In the past 4 months my dr has been watching my bloodwork for a slightly elevated d dimer .55 and ha...
Well, here it is two years later, and once more Giving Tuesday. As I made my donation this year, I once more thought back to my early days after Sara...
First things first, my sincere thanks for maintaining this forum in which people with a diagnosis or a suspicion of lung cancer can raise our doubts...
Register Now for the Targeted Therapies Patient Forum
My sister-in-law was diagnosed 10 years ago with stage 4 adenocarcinoma, with what now would be considered oligiomestastic disease. She had 6 rounds of Cisplatin/Alimta/Avastin followed by approximately 4 years of maintenance chemo (Alimta/Avastin). About 6 years ago they did a lobectomy. Her scans have been clear until a few weeks ago when they saw a 2.1 cm nodule and some ground glass opacity. She is now awaiting biopsy results.
Hi, 3 to 4 years prior to my diagnosis of small cell lung cancer I suffered from small fiber neuropathy, i am not sure if it is autoimmune related, there was some of autoimmune issues?
I have two questions, if that is ok?
1 is it likely that the neuropathy/autoimmune is related to my diagnosis of small cell.
2 if it is related, does this influence or rule out immunotherapy treatment.
In hope you understand my questions and concerns.
B.
This article was provided by Disability Benefits Help, an independent organization dedicated to helping people of all ages get Social Security disability benefits.
GRACE has partnered with Clinical Care Options (CCO) Oncology, to share a series of educational videos regarding Measurable Residual Disease (MRD) in acute lymphocytic leukemia (ALL).
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer. We are pleased to share with you the videos from the live webcast.
Our faculty discussed the following topics:
~Newer Technologies in Radiation
~Novel Indications for Local Therapy in Advanced NSCLC
~The Growing Potential Utility of Surgery in Advanced NSCLC
~Systemic Therapies for Advanced NSCLC
~Panel Discussion and Q&A
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.